[go: up one dir, main page]

NO933856D0 - Pediatrisk kombinasjonsvaksine - Google Patents

Pediatrisk kombinasjonsvaksine

Info

Publication number
NO933856D0
NO933856D0 NO933856A NO933856A NO933856D0 NO 933856 D0 NO933856 D0 NO 933856D0 NO 933856 A NO933856 A NO 933856A NO 933856 A NO933856 A NO 933856A NO 933856 D0 NO933856 D0 NO 933856D0
Authority
NO
Norway
Prior art keywords
combined
combination vaccine
vaccine composition
pediatric
vaccine
Prior art date
Application number
NO933856A
Other languages
English (en)
Other versions
NO308588B1 (no
NO933856L (no
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO933856D0 publication Critical patent/NO933856D0/no
Publication of NO933856L publication Critical patent/NO933856L/no
Publication of NO308588B1 publication Critical patent/NO308588B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
NO933856A 1992-10-27 1993-10-26 Kombinert pediatrisk vaksineblanding NO308588B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (3)

Publication Number Publication Date
NO933856D0 true NO933856D0 (no) 1993-10-26
NO933856L NO933856L (no) 1994-04-28
NO308588B1 NO308588B1 (no) 2000-10-02

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933856A NO308588B1 (no) 1992-10-27 1993-10-26 Kombinert pediatrisk vaksineblanding

Country Status (22)

Country Link
EP (1) EP0594950B1 (no)
JP (1) JPH07300427A (no)
KR (1) KR100289224B1 (no)
AT (1) ATE176157T1 (no)
AU (1) AU669570B2 (no)
CA (1) CA2109159A1 (no)
CZ (1) CZ283587B6 (no)
DE (2) DE69323264D1 (no)
DK (1) DK0594950T3 (no)
ES (1) ES2126616T3 (no)
FI (1) FI934725A7 (no)
GR (1) GR3029884T3 (no)
HU (1) HU215149B (no)
IL (1) IL107387A (no)
LV (1) LV12271B (no)
NO (1) NO308588B1 (no)
NZ (1) NZ250029A (no)
PL (1) PL174130B1 (no)
RU (1) RU2121365C1 (no)
SG (1) SG47725A1 (no)
TW (1) TW256774B (no)
UA (1) UA27754C2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024216A1 (en) * 1994-03-07 1995-09-14 Auckland Uniservices Limited Prevention of diabetes
BR9608612A (pt) * 1995-06-07 1999-05-04 Smithkline Beecham Biolog Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
EP1082965B1 (en) * 1995-06-23 2009-06-10 GlaxoSmithKline Biologicals S.A. A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
DK0914153T3 (da) * 1996-07-02 2007-01-29 Sanofi Pasteur Ltd Multivalente DTP-poliovacciner
GB0108364D0 (en) 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
SI1296715T2 (sl) * 2000-06-29 2016-03-31 Smithkline Beecham Biologicals S.A. Multivalentni sestavek cepiva
RU2175557C1 (ru) * 2000-09-04 2001-11-10 Волков Александр Григорьевич Способ предупреждения воспалительных заболеваний верхних дыхательных путей
EP1409013B1 (en) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
US8409587B2 (en) 2002-11-01 2013-04-02 Glaxosmithkline Biologicals S.A. Immunogenic composition
RU2231793C1 (ru) * 2003-03-11 2004-06-27 Москаленко Екатерина Петровна Способ оценки иммуногенности коклюшных вакцин
RU2244548C1 (ru) * 2003-07-17 2005-01-20 Оренбургская государственная медицинская академия (ОГМА) Средство, повышающее иммуногенные свойства столбнячного анатоксина
RU2274474C1 (ru) * 2004-10-12 2006-04-20 Государственное образовательное учреждение ВПО Красноярская государственная медицинская академия Министерства здравоохранения РФ Способ вакцинации детей против краснухи на крайнем севере
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
EP2201961B1 (en) 2005-06-27 2018-01-24 GlaxoSmithKline Biologicals S.A. Immunogenic composition
RU2303459C1 (ru) * 2005-12-05 2007-07-27 ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) Способ вакцинации детей против краснухи на крайнем севере
RU2299744C1 (ru) * 2006-03-02 2007-05-27 ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ сезонной ревакцинации детей против краснухи на крайнем севере

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
DK163176C (da) * 1985-09-27 1992-06-22 Schweiz Serum & Impfinst Ugiftig konjugatvaccine mod infektioner af pseudomonas aeruginosa- og escherichia coli- bakterier, fremgangsmaade til fremstilling heraf og anvendelse af vaccinen

Also Published As

Publication number Publication date
ES2126616T3 (es) 1999-04-01
FI934725L (fi) 1994-04-28
HU9303028D0 (en) 1994-01-28
NO308588B1 (no) 2000-10-02
DK0594950T3 (da) 1999-09-13
NO933856L (no) 1994-04-28
DE69323264D1 (de) 1999-03-11
HU215149B (hu) 2000-03-28
FI934725A7 (fi) 1994-04-28
PL174130B1 (pl) 1998-06-30
AU669570B2 (en) 1996-06-13
DE69323264T4 (de) 1999-10-14
IL107387A (en) 1997-04-15
FI934725A0 (fi) 1993-10-26
AU5029093A (en) 1994-05-12
JPH07300427A (ja) 1995-11-14
TW256774B (no) 1995-09-11
UA27754C2 (uk) 2000-10-16
GR3029884T3 (en) 1999-07-30
KR940008698A (ko) 1994-05-16
RU2121365C1 (ru) 1998-11-10
ATE176157T1 (de) 1999-02-15
DE69323264T2 (de) 1999-06-02
HK1009931A1 (en) 1999-06-11
CA2109159A1 (en) 1994-04-28
EP0594950A1 (en) 1994-05-04
KR100289224B1 (ko) 2001-05-02
CZ227293A3 (en) 1994-05-18
CZ283587B6 (cs) 1998-05-13
LV12271B (en) 1999-07-20
NZ250029A (en) 1994-09-27
HUT67239A (en) 1995-03-28
IL107387A0 (en) 1994-01-25
SG47725A1 (en) 1998-04-17
EP0594950B1 (en) 1999-01-27
LV12271A (lv) 1999-05-20

Similar Documents

Publication Publication Date Title
NO933856D0 (no) Pediatrisk kombinasjonsvaksine
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
GR3035081T3 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
NO913812L (no) Oligosakkaridkonjugatvaksiner.
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
NO179164C (no) Fremgangsmåte for fremstilling av et immunogenkonjugat
DE69518978D1 (de) Gruppe a streptokokkenpolysaccharide immunogen-zusammensetzungen und verfahren
DE68915046D1 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
US6165468A (en) Antigenic carbohydrate linked to an immunogenic carrier
WO2002038611A3 (en) Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins
Egorkov et al. Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.
MÄKELÄ et al. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine
SE8400934L (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003